Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biogen Moves Into Neuropsychiatry With Pfizer AMPA Receptor Modulator

Mar 12 2018

• By Joseph Haas

Human brain illustrated with millions of small nerves - Conceptual 3d render

Related Content

Biogen, AbbVie Withdraw Struggling MS Drug Zinbryta Due To Safety Issues

Mar 02 2018

Pfizer Exits Early Neuroscience, But M&A Could Allow Later Re-Entry

Jan 09 2018

Biogen Spooks With Phase III Aducanumab Changes

Feb 15 2018

A Deal For Biogen, But Not The One Investors Are Waiting For

Jan 25 2018

Related Companies

Biogen, Inc.

Pfizer Inc.

AbbVie Inc.

Karyopharm Therapeutics

Additional Topics

Deals Research & Development Business Strategies Companies Neurology BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window